Left iliac total vein extravascular stent and operation method
By implanting a silicone rubber stent for the left common iliac vein outside the blood vessel, the problems of displacement, restenosis, and material fatigue associated with internal stents have been solved. This approach achieves close fit to the blood vessel and long-term patency, thus improving the treatment outcome of the iliac vein.
Patent Information
- Application Number
- CN202511999160.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-29
- Publication Date
- 2026-02-06
- Estimated Expiration
- 2045-12-29
AI Technical Summary
Existing built-in iliac vein stents have problems such as stent migration, restenosis, intimal hyperplasia, material fatigue and poor biocompatibility, making them difficult to adapt to the complex anatomical structure of the iliac vein and difficult to operate.
The procedure employs an extravascular implantation method, using a stent made of silicone rubber for the left common iliac vein. The stent is designed as a one-piece structure, with the mid-segment connecting the stent forming a 135°~145° angle with the inferior vena cava stent and the left iliac vein stent. It is equipped with an elastic limiting clamp and is precisely implanted through minimally invasive surgery to ensure a tight fit between the stent and the outer wall of the blood vessel.
It significantly reduces the risk of intimal hyperplasia and thrombosis, improves anti-fatigue performance, reduces hemodynamic disturbances, enhances the compatibility of stents with blood vessels, reduces operational difficulty and the risk of complications, and improves long-term patency and safety.